Cerebrospinal fluid ratios with Aβ(42) predict preclinical brain β-amyloid accumulation

INTRODUCTION: Biomarkers are urgently needed for the critical yet understudied preclinical stage of Alzheimer's disease (AD). METHODS: Cerebrospinal fluid (CSF) collection, [C-11]Pittsburgh compound B (PiB) amyloid imaging, and magnetic resonance imaging were acquired in 104 cognitively healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Racine, Annie M., Koscik, Rebecca L., Nicholas, Christopher R., Clark, Lindsay R., Okonkwo, Ozioma C., Oh, Jennifer M., Hillmer, Ansel T., Murali, Dhanabalan, Barnhart, Todd E., Betthauser, Tobey J., Gallagher, Catherine L., Rowley, Howard A., Dowling, N. Maritza, Asthana, Sanjay, Bendlin, Barbara B., Blennow, Kaj, Zetterberg, Henrik, Carlsson, Cynthia M., Christian, Bradley T., Johnson, Sterling C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
CSF Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778249/
https://www.ncbi.nlm.nih.gov/pubmed/26955655
http://dx.doi.org/10.1016/j.dadm.2015.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778249/
https://www.ncbi.nlm.nih.gov/pubmed/26955655
http://dx.doi.org/10.1016/j.dadm.2015.11.006

Ejemplares similares